December 2012 Issue of Dialogues
Includes 3 Interviews:
Methicillin-resistant Staphylococcus aureus
by: Dirk M. Elston,
MD interviewed by Maurice A. Thew, MD
by: Peggy Wu, MD interviewed
by Christine J. Ko, MD
Vaccines (Part 2)
by: Stephen Trying, MD interviewed by Gary Brauner,
Target Audience: Dermatologists and other health care
professionals who wish to access and update their current knowledge of
Learning Objectives: At the conculsion of this activity,
participants should be able to:
1. Identify vaccinations that are safe for
immunosuppressed patients to avoid risk of infection.
2. Recognize abscess
drainage is an effective treatment for Methicillin-resistant Staphylococcus
3. Avoid over prescription of antibiotics in cases where drainage may
be effective treatment of Methicillin-resistant Staphylococcus aureus.
Identify the patient population that would most benefit from the herpes zoster
vaccine and offer vaccination.
CME credit is only available to purchasers. CME expires November,
The American Academy of
Dermatology is accredited by the Accreditation Council for Continuing Medical
Education to provide continuing medical education for physicians.
American Academy of Dermatology designates this enduring material for a maximum
of 2.00 AMA PRA Category 1 Creditsï¿½. Physicians should claim only the
credit commensurate with the extent of their participation in the activity.
AAD Recognized Credit Statement
Dialogues in Dermatology
is recognized by the American Academy of Dermatology for 2.00 AAD Recognized
Credit and may be used toward the AAD Continuing Medical Education Award.
Supported browsers: FireFox (3+),
Google Chrome (5+), Internet Explorer (7+), Safari (5+), Opera (10+).
Adobe Reader (or other PDF reader) to
view PDF files.